Correlation Between Acrivon Therapeutics, and Acurx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Acrivon Therapeutics, and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Acurx Pharmaceuticals.

Diversification Opportunities for Acrivon Therapeutics, and Acurx Pharmaceuticals

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Acrivon and Acurx is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Acurx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and Acurx Pharmaceuticals

Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.93 times more return on investment than Acurx Pharmaceuticals. However, Acrivon Therapeutics, Common is 1.07 times less risky than Acurx Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about 0.0 per unit of risk. If you would invest  1,231  in Acrivon Therapeutics, Common on August 31, 2024 and sell it today you would lose (473.00) from holding Acrivon Therapeutics, Common or give up 38.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Acrivon Therapeutics, Common  vs.  Acurx Pharmaceuticals LLC

 Performance 
       Timeline  
Acrivon Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Acurx Pharmaceuticals LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Acrivon Therapeutics, and Acurx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acrivon Therapeutics, and Acurx Pharmaceuticals

The main advantage of trading using opposite Acrivon Therapeutics, and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.
The idea behind Acrivon Therapeutics, Common and Acurx Pharmaceuticals LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments